BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 27639451)

  • 1. Characterization of cervical lymph-nodes using a multi-parametric and multi-modal approach for an early prediction of tumor response to chemo-radiotherapy.
    Scalco E; Marzi S; Sanguineti G; Vidiri A; Rizzo G
    Phys Med; 2016 Dec; 32(12):1672-1680. PubMed ID: 27639451
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diffusion-weighted magnetic resonance imaging early after chemoradiotherapy to monitor treatment response in head-and-neck squamous cell carcinoma.
    Vandecaveye V; Dirix P; De Keyzer F; Op de Beeck K; Vander Poorten V; Hauben E; Lambrecht M; Nuyts S; Hermans R
    Int J Radiat Oncol Biol Phys; 2012 Mar; 82(3):1098-107. PubMed ID: 21514067
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Response evaluation after chemoradiotherapy for advanced nodal disease in head and neck cancer using diffusion-weighted MRI and 18F-FDG-PET-CT.
    Schouten CS; de Graaf P; Alberts FM; Hoekstra OS; Comans EF; Bloemena E; Witte BI; Sanchez E; Leemans CR; Castelijns JA; de Bree R
    Oral Oncol; 2015 May; 51(5):541-7. PubMed ID: 25725587
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The prediction of the treatment response of cervical nodes using intravoxel incoherent motion diffusion-weighted imaging.
    Marzi S; Piludu F; Sanguineti G; Marucci L; Farneti A; Terrenato I; Pellini R; Benevolo M; Covello R; Vidiri A
    Eur J Radiol; 2017 Jul; 92():93-102. PubMed ID: 28624026
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Imaging strategy for response evaluation to chemoradiotherapy of the nodal disease in patients with head and neck squamous cell carcinoma.
    Nishimura G; Yabuki K; Hata M; Komatsu M; Taguchi T; Takahashi M; Shiono O; Sano D; Arai Y; Takahashi H; Chiba Y; Oridate N
    Int J Clin Oncol; 2016 Aug; 21(4):658-667. PubMed ID: 26710795
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Weekly response assessment of involved lymph nodes to radiotherapy using diffusion-weighted MRI in oropharynx squamous cell carcinoma.
    Tyagi N; Riaz N; Hunt M; Wengler K; Hatzoglou V; Young R; Mechalakos J; Lee N
    Med Phys; 2016 Jan; 43(1):137. PubMed ID: 26745906
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnostic value of only 18F-fluorodeocyglucose positron emission tomography/computed tomography-positive lymph nodes in head and neck squamous cell carcinoma.
    Lee SH; Huh SH; Jin SM; Rho YS; Yoon DY; Park CH
    Otolaryngol Head Neck Surg; 2012 Oct; 147(4):692-8. PubMed ID: 22535915
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of computed tomography in the management of the neck after chemoradiotherapy in patients with head-and-neck cancer.
    Clavel S; Charron MP; Bélair M; Delouya G; Fortin B; Després P; Soulières D; Filion E; Guertin L; Nguyen-Tan PF
    Int J Radiat Oncol Biol Phys; 2012 Feb; 82(2):567-73. PubMed ID: 21310545
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Utility of MRI with morphologic and diffusion weighted imaging in the detection of post-treatment nodal disease in head and neck squamous cell carcinoma.
    Mundada P; Varoquaux AD; Lenoir V; de Vito C; Dulguerov N; Ailianou A; Caparrotti F; Becker M
    Eur J Radiol; 2018 Apr; 101():162-169. PubMed ID: 29571791
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Apparent diffusion coefficient for lymph node characterization after chemoradiation therapy for locally advanced rectal cancer.
    Kim SH; Ryu KH; Yoon JH; Lee Y; Paik JH; Kim SJ; Jung HK; Lee KH
    Acta Radiol; 2015 Dec; 56(12):1446-53. PubMed ID: 25425724
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictive markers, including total lesion glycolysis, for the response of lymph node(s) metastasis from head and neck squamous cell carcinoma treated by chemoradiotherapy.
    Nishimura G; Komatsu M; Hata M; Yabuki K; Taguchi T; Takahashi M; Shiono O; Sano D; Arai Y; Takahashi H; Chiba Y; Oridate N
    Int J Clin Oncol; 2016 Apr; 21(2):224-230. PubMed ID: 26272533
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Utility of pretreatment mean apparent diffusion coefficient and apparent diffusion coefficient histograms in prediction of outcome to chemoradiation in head and neck squamous cell carcinoma.
    Srinivasan A; Chenevert TL; Dwamena BA; Eisbruch A; Watcharotone K; Myles JD; Mukherji SK
    J Comput Assist Tomogr; 2012; 36(1):131-7. PubMed ID: 22261783
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlation of Computerized Tomography density patterns of lymph nodes with treatment results and outcome in head and neck cancer patients treated by 2 different chemoradiotherapy schedules.
    Jaju S; Gupta SK; Pandey S; Singh V
    J Cancer Res Ther; 2014; 10(2):284-93. PubMed ID: 25022379
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Target Volume Delineation Based on Diffusion-weighted magnetic Resonance Imaging for Locally Advanced Head and Neck Cancer.
    DE Felice F; Musio D; Bulzonetti N; Maghella F; Tombolini V
    Anticancer Res; 2016 Aug; 36(8):4181-5. PubMed ID: 27466529
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Validity of 3-Tesla diffusion-weighted magnetic resonance imaging for distinction of reactive and metastatic lymph nodes in head-and-neck carcinoma.
    Vijayalakshmi K; Raghuram PH; Saravanan K; Krithika CL; Kannan A
    J Cancer Res Ther; 2020; 16(3):587-593. PubMed ID: 32719272
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Head and neck squamous cell carcinoma: value of diffusion-weighted MR imaging for nodal staging.
    Vandecaveye V; De Keyzer F; Vander Poorten V; Dirix P; Verbeken E; Nuyts S; Hermans R
    Radiology; 2009 Apr; 251(1):134-46. PubMed ID: 19251938
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of 18F-FDG PET/CT and CT/MRI with histopathologic correlation in patients undergoing salvage surgery for head and neck squamous cell carcinoma.
    Kim SY; Kim JS; Yi JS; Lee JH; Choi SH; Nam SY; Cho KJ; Lee SW; Kim SB; Roh JL
    Ann Surg Oncol; 2011 Sep; 18(9):2579-84. PubMed ID: 21409485
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diffusion-Weighted MRI in the Assessment of Early Treatment Response in Patients with Squamous-Cell Carcinoma of the Head and Neck: Comparison with Morphological and PET/CT Findings.
    Martins EB; Chojniak R; Kowalski LP; Nicolau UR; Lima EN; Bitencourt AG
    PLoS One; 2015; 10(11):e0140009. PubMed ID: 26562784
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intravoxel incoherent motion diffusion-weighted MRI during chemoradiation therapy to characterize and monitor treatment response in human papillomavirus head and neck squamous cell carcinoma.
    Paudyal R; Oh JH; Riaz N; Venigalla P; Li J; Hatzoglou V; Leeman J; Nunez DA; Lu Y; Deasy JO; Lee N; Shukla-Dave A
    J Magn Reson Imaging; 2017 Apr; 45(4):1013-1023. PubMed ID: 27862553
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prospective, longitudinal, multi-modal functional imaging for radical chemo-IMRT treatment of locally advanced head and neck cancer: the INSIGHT study.
    Welsh L; Panek R; McQuaid D; Dunlop A; Schmidt M; Riddell A; Koh DM; Doran S; Murray I; Du Y; Chua S; Hansen V; Wong KH; Dean J; Gulliford S; Bhide S; Leach MO; Nutting C; Harrington K; Newbold K
    Radiat Oncol; 2015 May; 10():112. PubMed ID: 25971451
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.